Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s (AZN) IMFINZI, ...

The recent price drop in British American Tobacco shares presents a potential buying opportunity. Read more on what's next ...

In the hush between star-bright infinities and the hum of everyday tasks, a quiet summons persists. No single measurement or ...

Mesoblast's high-risk programs drive inflated valuation. Find out why MESO stock remains a "sell" as execution risks outweigh ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New ...